This protocol describes the preparation of in vitro bovine articular cartilage for imaging in high resolution with X-rays. These explants actively undergo postnatal maturation. We describe here the necessary steps from the biopsy to data analysis of 3D X-ray phase contrast imaging, passing through explant culture, tissue fixation and synchrotron preparation.
Understanding the mechanisms that underpin post-natal maturation of articular cartilage is of crucial importance for designing the next generation of tissue engineering strategies and potentially repairing diseased or damaged cartilage. In general, postnatal maturation of the articular cartilage, which is a wholesale change in collagen structure and function of the tissue to accommodate growth of the organism, occurs over a timescale ranging from months to years. Conversely dissolution of the structural organization of the cartilage that also occurs over long timescales is the hallmark of tissue degeneration. Our ability to study these biological processes in detail have been enhanced by the findings that growth factors can induce precocious in vitro maturation of immature articular cartilage. The developmental and disease related changes that occur in the joint involve bone and cartilage and an ability to co-image these tissues would significantly increase our understanding of their intertwined roles.
The simultaneous visualization of soft tissue, cartilage and bone changes is nowadays a challenge to overcome for conventional preclinical imaging modalities used for the joint disease follow-up. Three-dimensional X-ray Phase-Contrast Imaging methods (PCI) have been under perpetual developments for 20 years due to high performance for imaging low density objects and their ability to provide additional information compared to conventional X-ray imaging.
In this protocol we detail the procedure used in our experiments from biopsy of the cartilage, generation of in vitro matured cartilage to data analysis of image collected using X-ray phase contrast imaging.
Immature articular cartilage is an adequate support to initiate morphological, structural and biomolecular changes1 in order to obtain an adult joint-specific function. The principal change is reorganization of collagen fibrils from one displaying a parallel orientation with respect to the surface in immature cartilage to one where fibrils deeper in the tissue are perpendicular in mature cartilage. Pseudo-stratification of adult cartilage is evident through the reorganization of resident chondrocytes along the direction of collagen fibril orientation with cells at the surface disc-like and parallel to the surface and in the deeper zones cells becoming progressively larger and organized in columns. Post-natal maturation is known to occur over many months and is essentially completed at the end of puberty, the long timescale was thought to make studying this important developmental transition at best difficult or technically impossible to study in detail2. Some advances into the solution to this problem have been made through the finding that fibroblast growth factor-2 and transforming growth factor-β1 together are able to induce important physiological and morphological changes that replicate articular cartilage maturation2,3 (Figure 1). Growth factor-induced in vitro maturation occurs within three weeks and does not require any biomechanical input. After culture, collagen type II expression is significantly reduced and the ratio of mature trivalent to immature divalent collagen crosslinks increases as is seen in maturing cartilage. Also, the organization of the extracellular matrix and collagen fibrils is closer to that seen in mature cartilage though this facet of transition is not complete. Biochemically, the composition of growth factor-treated cartilage is mimicking an adult articular cartilage3.
The model used in the article is based on an in vitro culture of 4- or 6-mm diameter explants that were excised under sterile conditions from the lateral aspect of the metacarpophalangeal joint medial condyle from immature male (7 days-old) bovine steers. A thin layer of calcified cartilage and subchondral bone was kept on the basal aspect of each explant. The articular cartilage were cultured in a classical serum-free medium Dulbecco's modified Eagles medium (high glucose 4.5 g/L) in which insulin-transferrin-selenium (ITS), 10 mM HEPES buffer pH 7.4, ascorbic acid and 50 µg/mL gentamicin were added. This culture medium is supplemented with 100 ng/mL fibroblast growth factor 2 (FGF-2) and 10 ng/mL transforming growth factor β1 (TGF-β1) that are replenished every third day with media changes2. Highly accelerated cartilage maturation is induced by combining growth factors. These changes occur within 21 days. Growth factor stimulation additionally induces apoptosis and resorption from the basal aspect and cellular proliferation in surface chondrocytes3. The culture medium composition is described in Table 1. Following the model developed by Khan et al. 20112, articular cartilage explants are cultured with TGF-β1 at a concentration of 10 ng/µL and FGF2 at 100 ng/µL concentration (stock concentrations 10 μg/mL and 100 μg/mL dissolved in phosphate buffered saline/0.1% BSA). 1 µL of each growth factor is used per 1 mL of the medium. DMEM-F12 with L- glutamine and high glucose is an artificial medium which, once supplemented with insulin, transferrin and selenium (ITS), ascorbic acid, gentamicin and HEPES provides a complete medium supplementation with all the physiological growth requirements specific to the different cell lines and explants cultures. DMEM-F12 is composed of several diverse inorganic salts (i.e., NaCl, KCl, CaCl2, MgCl2, NaH2PO4), glucose, amino acids (nitrogen sources), vitamins, co-factors and water. Those salts provide adequate energetic inputs to sustain the cellular survival and normal growth in culture. The mineral ions contribute to maintaining the osmolarity close to the natural physiological environment. The higher concentration of glucose (4.5 g/L) is used as chondrocytes respire primarily through glycolysis. F12 medium supplementation is used because it offers number of sources of sulfate, CuSO4, FeSO4, ZnSO4 and MgSO4 required for sulfated glycosaminoglycan synthesis. As checked by colored indicators (here phenol red) and CO2/HCO–3 buffer combined with phosphates, the pH remains constant at a value close to 7.4. The major respiratory pathway used by chondrocytes is glycolysis where lactic acid is the end product which causes an increase in pH, therefore, in the absence of biomechanical forces that would help to remove locally produced lactic acid, HEPES acts to maintain a buffered environment for physiological processes. Gentamicin is an aminoglycoside antibiotic controls external bacterial contamination through inhibition of growth. Ascorbic acid is used as medium complement for its anti-oxidant action4. Ascorbic acid is a co-factor for enzymes, prolyl hydroxylases, that function to hydroxylate proline residues in collagen stabilizing its triple helical structure. The transferrin usually serves as extracellular antioxidant (toxicity and ROS reductions)5,6. It is also added to the culture medium for its ability to provide and facilitate extracellular iron storage and transport in cell culture. Transferrin binds iron so tightly under physiological conditions that virtually no free iron exists to catalyze the production of free radicals7. The insulin hormone signaling from its bound receptor increases the absorption of several elements such as glucose, amino acids. It is also involved in several processes such as intracellular transport, lipogenesis, protein, and nucleic acid syntheses. Insulin has a growth-promoting effect. Selenium is present additionally in the composite solution “insulin-transferrin-selenium”, as sodium selenite. It is mainly used as a cofactor for (seleno-) proteins such gluthatione peroxidase (GPX), as supplementary antioxidant agent in the culture. In in vitro articular chondrocytes, ITS seems to enhance cellular proliferation and phenotype preservation by inhibiting the gene expression related to cellular dedifferentiation and hypertrophic differentiation8. Growth factors like fibroblast growth factor-2 and transforming growth factor-β1 are added to the culture medium. They are used to induce and regulate cell differentiation, growth, healing, and development2,3. FGF-2 and TGF-β1 in combination also potently promote cellular proliferation in cultured cells and tissues9.
This in vitro maturation model of articular cartilage is useful for three main reasons. First, the accelerated developmental phase transition in this model allows us to study imperceptible changes that occur over many months in in vivo models such as the elevated expression of lysl oxidase-L1 during maturation10. Secondly, tissue engineering of articular cartilage suffers from the fact that cartilage with an isotropic morphology and structure is produced which is functionally deficient when transplanted into joints to repair focal defects. Understanding how to induce maturational changes will accelerate the development of fully functional implantable devices. Thirdly and pertinent to this study, there are degenerative joint conditions such as Kashin-Beck disease occurring during childhood that lead to severe joint deformities in adulthood. This particular disease is strongly associated to geographic areas (China) with endemic deficiencies in selenium and iodine potentially affecting tens of millions of inhabitants11,12,13. Examination of skeletal defects in Kashin-Beck disease show that it occurs peri-pubertally, implicating perturbation of skeletal maturational processes. Therefore, to further understand the role of selenium in articular cartilage (AC) a robust model for cartilage growth and development is required. An in vitro growth factor-induced model of maturation provides a useful starting point for studies on the growth and metabolism of articular cartilage during maturation in presence or absence of selenium ions14,15,16. Our knowledge of the effects of selenium (Se) deficiency on complex and inter-related biological processes remains very poor. The main problem lies in the fact that selenium remains an element to study due to its restrictive action range (required concentration between 40 and 400 µg/kg17) and the very low concentration involved. The accelerated maturation model using immature bovine cartilage offers an unprecedented ability to look at biological changes that occur during an important phase of development. The Se-concentration in organisms is tightly controlled, and this model is a starting point to develop imaging techniques allowing its precise tracking during maturation. These techniques could then be a powerful tool to study strategies to prevent AC degradation and potentially to develop the basis of novel regenerative medicine-based therapies.
Simultaneous visualization of soft tissue, cartilage and bone changes is a major challenge in conventional preclinical imaging modalities. This would be indeed an important help for joint disease follow-up18,19 . As an example, conventional X-ray micro Computed Tomography (µCT) presents poor performances for soft tissue that limit its use to the depiction of bone defects, osteophytes, and indirect visualization of cartilage. Magnetic Resonance Imaging (MRI), on the other hand, is conventionally employed for soft tissue imaging despite its poor ability to precisely render changes in the bone (e.g., micro-calcifications) during initial stages of diseases. The ability to be sensitive to bones and cartilages, and to distinguish the constitutive cells of cartilage, chondrocytes is of tremendous importance. Phase Contrast Imaging (PCI) relies on the property that the X-rays refraction index of materials can be a thousand times greater than the absorption index for light elements. This generates a higher contrast for soft tissues in comparison to the conventional methods based on the sole absorption. Therefore, PCI is able to image all the tissues that constitute the joint having concurrent representation of both high absorbing (e.g., bones) and less absorbing tissues (e.g., fibrous cartilage, ligaments, tendons, meniscus and associated soft tissues (synovial membranes and muscle))18,19,20,21.
As demonstrated in ref.20, X-ray PCI outperforms the other preclinical imaging modalities for cartilage. The purpose of this protocol is to detail the procedure and to show some representative results. Scheme of the effect of growth factors on immature cartilage explant is shown in Figure 1.
We presented a complete study from the sample preparation to the image visualization, including the data acquisition protocols, for the study of in vitro fast maturating articular cartilage. Results of a synchrotron imaging session showed the goodness of the model.
In the model presented here, some observations and limits must be mentioned. This “accelerated maturation” occurs within 21 days of culture. For longer culture periods, explant plugs begin to degrade with change…
The authors have nothing to disclose.
Authors thank the ESRF for providing in house beamtime. Authors would like to thank Eric Zieglerfor scientific discussions. The described PCI experiment was conducted at the beamline BM05 of the European Synchrotron Radiation Facility (ESRF), Grenoble, France. CB thanks Explora’doc Auvergne Rhone Alpes and scholarships from the University of Swansea and the Université Grenoble Alpes for funding part of this study.
Material : Biological products | |||
DMEM/F-12 (1:1) (1X) + GlutaMAX Dulbecco's Modified Eagle Medium F-12 Nutriment Mixture (Ham) 500mL | Gibco by life technologies | 31331-028 | |
Gentamicin Reagent Solution, 50 mg/mL | Gibco by life technologies | 15750-060 | |
HEPES, special preparation, 1M, pH 7.5 filtered | Sigma | H-3375 | |
ITS, Insulin-Transferrin-Selenium | Gibco by life technologies | 51500-057 | |
L-Ascorbic Acid-2-Phosphate, sesquimagnesium salf hydrate, 95% | Sigma | A8960-5G | |
Neutral Buffer Formalin (NBF) | Sigma Aldrich | HT501128 | |
phosphate buffered saline (PBS) pH 7.4 | Gibco by life technologies | 10010023 | |
Culture equipments: | |||
Absordent Protector,Benchkote | WhatmanTM | Cat No. 2300731, | Polysterene Backed, 460cm*50m |
Accurpette VWR | |||
Autoclavable Disposal Bag | For disposal of contamined plastic laboratory ware neck should be left open to allow penetration of steam, Hazardous Waste, STERILIN (white bag) | ||
biopsy punches | MILTEX by KAI | ref 33-36 | 4 & 6 mm diameter |
Clinical waste for alternative treatment Medium Duty | (UN-approved weight 5kg, Un-closure methods, UN- SH4/Y5/S/II/GB/4/06 (orange bag) | ||
Eppendorf tubes | 0.5mL and 1.5 mL | ||
Falcon tubes | 15mL and 50 mL | ||
free of detectable RNase, DNase, DNA&Pyrogens 1000ul Bevelled Graduated, filter tip | Starlab, TipOne (sterile) | S1122-1830 | |
free of detectable RNase, DNase, DNA&Pyrogens 20µl Bevelled Graduated, filter tip | Starlab, TipOne (sterile) | S1120-1810 | |
free of detectable RNase, DNase, DNA&Pyrogens 200ul Bevelled Graduated, filter tip | Starlab, TipOne (sterile) | S1110-1810 | |
Incubator | Incubator at 37°C, humidified atmosphere with 5% CO2 | ||
Optical microscope | |||
Pipette-boy | 25mL-, 10mL-, and 5mL sterile plastic-pipettes | ||
Pipettes (25-10-5 ml) | CellStar, Greiner Bio-one | ||
Plastic tweezers | Oxford Instrument | AGT 5230 | |
Scalpel | |||
Tips | P1000, P200 and P10 with P1000, P200 and P10 tips (sterile) | ||
Tissue culture hood | |||
Vacuum pump | |||
Water bath 37°C | |||
well plates | 12 & 24 well plates | ||
Protection equipment: | |||
face shield | |||
gloves | |||
lab coat | |||
safety goggles | |||
Data acquisition equipment: | |||
Fiji software | open source Software | ||
PyHST reconstruction toolkit | open source Software |
.